Bayer's Finerenone Stacks Up More CV Benefit Data Ahead Of Potential Approval

 
• By Jessica Merrill
Heart health
Bayer's finerenone showed a significant benefit in a CV outcomes trial • Source: Alamy

More from Genitourinary

More from Therapeutic Category